SCHEMBL14583742

SCHEMBL14583742

C=C[C@H](COS(C)(=O)=O)N1C(=O)c2ccccc2C1=O

nearest known ligand 0.42

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ CASP3 P42574 3/20 0.41
▸ ALDH1A1 P00352 3/20 0.39
▸ TDP1 Q9NUW8 1/20 0.38
▸ PDE4A P27815 2/20 0.36
▸ PDE4B Q07343 2/20 0.36
▸ PDE4C Q08493 2/20 0.36
▸ PDE4D Q08499 2/20 0.36
▸ MAPT P10636 2/20 0.36
▸ NPSR1 Q6W5P4 2/20 0.34
▸ LMNA P02545 1/20 0.34
▸ KDM4E B2RXH2 1/20 0.34
▸ CYP1A2 P05177 1/20 0.34
▸ CYP3A4 P08684 1/20 0.34
▸ HPGD P15428 1/20 0.34
▸ XBP1 P17861 1/20 0.34
▸ CYP2C19 P33261 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17591381 0.82 ALDH1A1 (0.42) CASP3ALDH1A1TDP1PDE4APDE4B
SCHEMBL5514759 0.79 TDP1 (0.53) CASP3ALDH1A1TDP1PDE4APDE4B
SCHEMBL5514761 0.79 TDP1 (0.53) CASP3ALDH1A1TDP1PDE4APDE4B
SCHEMBL12197537 0.78 CASP3 (0.46) CASP3ALDH1A1TDP1LMNAKDM4E
SCHEMBL16558903 0.78 CASP3 (0.46) CASP3ALDH1A1TDP1LMNAKDM4E
SCHEMBL5999905 0.75 TDP1 (0.39) CASP3ALDH1A1TDP1PDE4APDE4B
SCHEMBL13937945 0.74 TDP1 (0.46) CASP3ALDH1A1TDP1MAPTLMNA
SCHEMBL13937924 0.74 TDP1 (0.46) CASP3ALDH1A1TDP1MAPTLMNA
SCHEMBL2507608 0.74 ALDH1A1 (0.36) CASP3ALDH1A1TDP1MAPTNPSR1
SCHEMBL15320020 0.74 ALDH1A1 (0.36) CASP3ALDH1A1TDP1MAPTNPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7173059-B2 Intermediates useful in the synthesis of HIV-protease inhibitors and methods for preparing the same AGOURON PHARMACEUTICALS, INC. (US) 2007-02-06 — — US disclosed
US-7173059-B2 Intermediates useful in the synthesis of HIV-protease inhibitors and methods for preparing the same AGOURON PHARMACEUTICALS, INC. (US) 2007-02-06 — — US disclosed
Send feedback